Search the website

Keyword regkirona Remove keyword

List item

News: ETF warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-2

Last updated: 09/12/2022

tixagevimab / cilgavimab), Regkirona (regdanvimab), Ronapreve … https://www.ema.europa.eu/documents/overview/xevudy-epar-medicine-overview_en.pdf 4: Regkirona EPAR Regkirona | European Medicines Agency …

List item

News: Human medicines: highlights of 2021

Last updated: 15/02/2022

Vaccine Janssen Nuvaxovid Regkirona Ronapreve Spikevax Vaxzevria Xevudy Covid-19 Hukyndra Icatibant …

List item

News: COVID-19: EMA recommends authorisation of antibody medicine Xevudy

CHMP, Last updated: 16/12/2021

and follows the approval of Regkirona and Ronapreve in November …

List item

News: COVID-19: EMA recommends authorisation of two monoclonal antibody medicines

CHMP, Last updated: 12/11/2021

11/11/2021 Ronapreve and Regkirona are now authorised in the … casirivimab/imdevimab) and Regkirona (regdanvimab) for COVID-19 … Registration GmbH. With regard to Regkirona, the Committee recommended …

List item

News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021

CHMP, Last updated: 12/11/2021

Regkirona …

List item

News: EMA receives application for marketing authorisation for Regkirona (regdanvimab) for treating patients with COVID-19

CHMP, PDCO, PRAC, Last updated: 04/10/2021

marketing authorisation for Regkirona (regdanvimab) for treating … marketing authorisation for Regkirona (regdanvimab) for treating …

List item

News: EMA issues advice on use of regdanvimab for treating COVID-19

CHMP, Last updated: 26/03/2021

UNAUTHORISED PRODUCT Regkirona (regdanvimab) AVAILABLE … medicinal product for Use: Regkirona  Active substance(s …